泌尿系統手術器械市場－全球產業規模、佔有率、趨勢、機會及預測（依產品、應用、區域及競爭格局分類，2021-2031年）

全球泌尿系統手術器械市場預計將從 2025 年的 119.8 億美元成長到 2031 年的 189.3 億美元，複合年成長率達到 7.92%。

此細分市場包括用於診斷和治療泌尿系統和男性生殖器官疾病的專用醫療設備，例如內視鏡、雷射系統、體外碎石機和機器人平台。推動該市場發展的關鍵因素包括全球人口快速老化以及泌尿器官系統惡性腫瘤和慢性腎臟病率的上升，這些疾病需要頻繁的手術治療。例如，美國癌症協會估計，到2025年，美國將新增313,780例前列腺癌病例，凸顯了對精密手術器械的迫切需求，以應對這一重大的健康問題。

儘管市場呈現積極的成長趨勢，但由於操作複雜設備的熟練專業人員短缺，該市場仍面臨許多挑戰。人才短缺限制了可進行的手術數量，進而阻礙了新設備的普及，尤其是在醫療資源匱乏的地區。美國泌尿系統協會2025年的數據顯示，美國62%的縣都面臨泌尿系統短缺的問題，凸顯了嚴重的資源分配問題，這些問題限制了手術能力，並阻礙了市場的整體擴張。

市場促進因素

機器人和雷射手術技術的進步，透過提高手術精度和縮短患者復原時間，成為推動市場成長的主要催化劑。這些創新使得微創技術成為臨床實踐的優先選擇，使外科醫生能夠更有效率、更少地進行切除術和腎切除併發症等複雜手術。機器人平台與高清成像和關節活動功能的整合，正促使醫院採用這些設備以提供更高標準的醫療服務。這一轉變也體現在手術數據中。在2024年1月的新聞稿中，直覺外科公司（Intuitive Surgical）報告稱，2023年全球達文西手術量較2022年成長約22%，顯示機器人手術在泌尿系統領域的應用正在迅速擴展。

此外，泌尿系統疾病和慢性腎臟病（CKD）發病率的上升也推動了對專用診斷和手術器械的需求。隨著腎結石、尿失禁和腎衰竭等疾病負擔的加重，內視鏡、體外碎石機和透析相關設備的需求也隨之成長。英國腎臟護理協會（Renal Care UK）在2024年5月的一篇報導中指出，英國估計有720萬人患有1-5期慢性腎臟病，這是大規模的患者群體，需要長期的泌尿系統護理。這種疾病負擔轉化為製造商的利潤成長。波士頓科學公司（Boston Scientific）在2024年報告稱，其泌尿系統業務在2023年實現了19.64億美元的淨銷售額，同比成長10.8%，這主要得益於其結石治療產品線的強勁表現。

市場挑戰

合格的泌尿系統醫療設備操作人員短缺是市場擴張的一大障礙。由於這些手術器械需要訓練有素的專業人員才能安全操作，因此目前醫療專業人員的數量無法滿足手術需求。當醫療機構缺乏進行專業手術所需的人員時，它們就不願意投資額外的設備，這直接導致採購量下降和存貨周轉減慢。因此，儘管患者需求不斷成長，但人員短缺有效地限制了潛在市場規模。

泌尿系統領域本身的人口結構變化而進一步加劇。根據美國泌尿系統協會統計，到2024年，美國約有30%的泌尿系統將超過65歲，這預示著即將到來的退休潮可能會進一步擴大現有的人才缺口。因此，泌尿系統人員配備不足限制了手術頻率，進而抑制了醫療器材的普及，並降低了醫療設備製造商的收入潛力。

市場趨勢

隨著醫療機構日益重視感染控制和營運效率，拋棄式輸尿管鏡和膀胱鏡的快速普及正在改變其籌資策略。與需要耗費大量成本和時間進行再處理的傳統可重複使用器械不同，一次性器械消除了交叉感染的風險，並確保性能穩定可靠，無需維護。這種轉變在高流量醫療機構尤其顯著，因為消毒延遲會降低手術效率，迫使醫院選擇無菌替代方案。這種普及帶來的財務影響顯而易見。 2025年1月，Ambu A/S公司報告稱，其泌尿系統、耳鼻喉科和胃腸病業務部門實現了23.9%的有機收入成長，這主要得益於市場對一次性輸尿管鏡解決方案的持續需求。

此外，具備即時連接功能的智慧手術器械的開發，標誌著傳統機器人輔助技術的重大革新。製造商正將先進的運算能力和感測技術融入下一代平台，為外科醫生提供觸覺回饋和可操作的洞察，超越了純機械遠端操控設備的能力。這些智慧系統利用數據最佳化臨床工作流程，並提供先進的模擬訓練，從而提升外科醫生的技能和決策能力。市場已迅速接受這些先進平台。在2025年1月舉行的摩根大通醫療保健大會上，直覺外科公司透露，自其最新達文西5系統上市以來，已向客戶交付了362套。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球泌尿系統手術器械市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依產品分類（內視鏡、Envision系統、周邊設備、配件/耗材、其他）
  • 依應用領域（慢性腎臟病、良性攝護腺增生 (BPH)、尿道結石、尿失禁 (UI) 和骨盆器官脫垂(POP)、腫瘤、其他）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

6. 北美泌尿系統手術器械市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

7. 歐洲泌尿系統手術器械市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

8. 亞太地區泌尿系統手術器械市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

9. 中東和非洲泌尿系統手術器械市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章 南美洲泌尿系統手術器械市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球泌尿系統手術器械市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Medtronic plc
• Boston scientific corporation
• Karl Storz GmbH & Co. KG
• Cook Medical Inc
• Richard Wolf GmbH
• Teleflex Incorporated
• Coloplast Corp.
• CONMED Corporation
• CR Bard Inc.
• Olympus Corporation

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Urology Surgical Instruments Market is projected to expand from USD 11.98 Billion in 2025 to USD 18.93 Billion by 2031, achieving a compound annual growth rate of 7.92%. This sector comprises a specialized range of medical devices, such as endoscopes, laser systems, lithotripters, and robotic platforms, all engineered for diagnosing and treating conditions of the urinary tract and male reproductive organs. The primary factors driving this market include a rapidly aging global population and increasing rates of urological malignancies and chronic kidney diseases, which demand frequent surgical care. For instance, the American Cancer Society estimates that there will be 313,780 new cases of prostate cancer in the United States in 2025, emphasizing the urgent need for precise surgical tools to address this significant health burden.

Despite these positive growth trends, the market faces a substantial obstacle due to a shortage of skilled specialists needed to operate these complex instruments. This gap in the workforce restricts the number of procedures that can be carried out, especially in underserved areas, which in turn limits the adoption of new equipment. Data from the American Urological Association in 2025 revealed that 62% of counties in the United States lack a practicing urologist, highlighting a severe distribution issue that constrains procedural capacity and hampers broader market expansion.

Market Driver

Technological progress in robotic-assisted and laser surgery serves as a key catalyst for market growth by improving surgical precision and shortening patient recovery times. These innovations have led to a clinical preference for minimally invasive techniques, enabling surgeons to perform complex operations like prostatectomies and nephrectomies with greater efficacy and fewer intraoperative complications. The integration of high-definition imaging and articulation in robotic platforms encourages hospitals to adopt this equipment to provide superior standards of care. This shift is reflected in procedural data; Intuitive Surgical reported in its January 2024 press release that worldwide da Vinci procedures increased by approximately 22% in 2023 compared to 2022, demonstrating the rapid growth of robotic usage in urology.

Furthermore, the rising incidence of urological disorders and chronic kidney diseases (CKD) fuels the demand for specialized diagnostic and surgical tools. As the burden of conditions such as kidney stones, urinary incontinence, and renal failure grows, there is a corresponding need for endoscopes, lithotripters, and dialysis-related devices. Kidney Care UK noted in a May 2024 article that an estimated 7.2 million people in the United Kingdom suffer from chronic kidney disease stages 1-5, representing a large patient population requiring long-term urological care. This disease burden translates into financial growth for manufacturers; Boston Scientific reported in 2024 that its Urology business generated net sales of $1.964 billion in 2023, a 10.8% increase driven by strong results in its stone management portfolio.

Market Challenge

The shortage of qualified specialists capable of operating complex urological devices creates a significant barrier to market advancement. Because these surgical instruments require highly trained professionals for safe operation, the current workforce struggles to keep up with the demand for procedures. When healthcare facilities lack the necessary personnel to perform specialized interventions, they are less likely to invest in additional equipment, which directly reduces procurement volumes and slows inventory turnover. Consequently, this workforce constraint effectively caps the total addressable market, regardless of the rising needs of patients.

This labor shortage is further aggravated by demographic shifts within the medical specialty itself. According to the American Urological Association, approximately 30 percent of practicing urologists in the United States were aged 65 years or older in 2024, indicating an approaching wave of retirements that threatens to widen the existing supply gap. As a result, the inability to fully staff urology departments limits the frequency of surgical procedures, thereby restricting the adoption rate of instrumentation and diminishing revenue potential for device manufacturers.

Market Trends

The rapid shift toward Single-Use Disposable Ureteroscopes and Cystoscopes is transforming procurement strategies as healthcare providers focus on infection control and operational efficiency. Unlike traditional reusable devices that demand expensive and time-consuming reprocessing, single-use instruments eliminate the risk of cross-contamination and ensure consistent performance without maintenance delays. This transition is especially prevalent in high-volume settings where sterilization lags can slow down procedural throughput, pushing hospitals to choose sterile alternatives. The financial impact of this adoption is evident; Ambu A/S reported in January 2025 that its Urology, ENT, and GI business group achieved 23.9% organic revenue growth, driven largely by sustained demand for its disposable ureteroscopy solutions.

Additionally, the development of Smart Surgical Instruments with Real-Time Connectivity marks a significant evolution beyond standard robotic assistance. Manufacturers are now embedding substantial computing power and sensing technologies into next-generation platforms to provide surgeons with haptic feedback and actionable insights, exceeding the capabilities of purely mechanical tele-manipulators. These intelligent systems use data to optimize clinical workflows and offer advanced simulation training, thereby enhancing surgeon proficiency and decision-making. The market has quickly embraced these sophisticated platforms; Intuitive Surgical revealed in a January 2025 presentation at the J.P. Morgan Healthcare Conference that 362 units of its latest da Vinci 5 system had been placed with customers since its commercial launch.

Key Market Players

• Medtronic plc
• Boston scientific corporation
• Karl Storz GmbH & Co. KG
• Cook Medical Inc
• Richard Wolf GmbH
• Teleflex Incorporated
• Coloplast Corp.
• CONMED Corporation
• C. R. Bard Inc.
• Olympus Corporation

Report Scope

In this report, the Global Urology Surgical Instruments Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Urology Surgical Instruments Market, By Product

• Endoscopes
• Envision Systems
• Peripheral Systems
• Accessories & Consumables
• Others

Urology Surgical Instruments Market, By Application

• Chronic Kidney Disease
• Benign Prostatic Hyperplasia (BPH)
• Urinary Stones
• Urinary Incontinence (UI) and Pelvic Organ Prolapse (POP)
• Oncology
• Others

Urology Surgical Instruments Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Urology Surgical Instruments Market.

Available Customizations:

Global Urology Surgical Instruments Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Urology Surgical Instruments Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Endoscopes, Envision Systems, Peripheral Systems, Accessories & Consumables, Others)
  • 5.2.2. By Application (Chronic Kidney Disease, Benign Prostatic Hyperplasia (BPH), Urinary Stones, Urinary Incontinence (UI) and Pelvic Organ Prolapse (POP), Oncology, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Urology Surgical Instruments Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Urology Surgical Instruments Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
  • 6.3.2. Canada Urology Surgical Instruments Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
  • 6.3.3. Mexico Urology Surgical Instruments Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application

7. Europe Urology Surgical Instruments Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Urology Surgical Instruments Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
  • 7.3.2. France Urology Surgical Instruments Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Urology Surgical Instruments Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Urology Surgical Instruments Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Urology Surgical Instruments Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application

8. Asia Pacific Urology Surgical Instruments Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Urology Surgical Instruments Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
  • 8.3.2. India Urology Surgical Instruments Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
  • 8.3.3. Japan Urology Surgical Instruments Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
  • 8.3.4. South Korea Urology Surgical Instruments Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Urology Surgical Instruments Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application

9. Middle East & Africa Urology Surgical Instruments Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Urology Surgical Instruments Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
  • 9.3.2. UAE Urology Surgical Instruments Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
  • 9.3.3. South Africa Urology Surgical Instruments Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application

10. South America Urology Surgical Instruments Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Urology Surgical Instruments Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
  • 10.3.2. Colombia Urology Surgical Instruments Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
  • 10.3.3. Argentina Urology Surgical Instruments Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Urology Surgical Instruments Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Medtronic plc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Boston scientific corporation
• 15.3. Karl Storz GmbH & Co. KG
• 15.4. Cook Medical Inc
• 15.5. Richard Wolf GmbH
• 15.6. Teleflex Incorporated
• 15.7. Coloplast Corp.
• 15.8. CONMED Corporation
• 15.9. C. R. Bard Inc.
• 15.10. Olympus Corporation

16. Strategic Recommendations

17. About Us & Disclaimer